Phase 3 Cardiovascular Complication Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
Non-small Cell Lung CancerCardiovascular Complication
Sun Yat-sen University524 enrolled1 locationNCT04980716
Recruiting
Phase 3
Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
Cardiovascular DiseasesCardiovascular ComplicationMyocardial Injury+2 more
Cantonal Hospital of St. Gallen880 enrolled1 locationNCT06279000
Recruiting
Phase 3
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
DeathAtrial FibrillationChronic Kidney Diseases+6 more
Region Stockholm1,400 enrolled34 locationsNCT05679024
Terminated
Phase 3
Comparison of standard current anaesthetics with Phaxan™, a new intravenous anaesthetic, for efficacy, safety profile and preservation of brain function after hip replacement surgery.
Decreased cognitive function after anaesthesia and hip surgeryCardiovascular complications of anaesthetics
Drawbridge Pharmaceuticals Pty Ltd40 enrolled1 locationACTRN12618000064202